Results 101 to 110 of about 5,371 (162)

Pharmaceutical considerations in treating neuropathic pain in athletes. [PDF]

Int Orthop
Ramtin S, Ilyas A.
europepmc   +1 more source

Total Synthesis and Pharmacological Evaluation of Phochrodines A-C. [PDF]

J Nat Prod
Bouchard JL, Chang S, Krishnan S, Presley CC, Boutaud O, Schley ND, Engers DW, Engers JL, Lindsley CW, Bender AM.   +9 more
europepmc   +1 more source

Efficacy of non-invasive brain stimulation combined with antidepressant medications for depression: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Syst Rev
Tao Y, Liang Q, Zhang F, Guo S, Fan L, Zhao F.   +5 more
europepmc   +1 more source

[Tricyclic antidepressive agents in insomnis. A commentary].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1971
openaire   +1 more source

[Tricyclic antidepressive agents in compulsive neuroses].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1968
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Azetidine derivatives of tricyclic antidepressant agents

Journal of Medicinal Chemistry, 1979
AbstractAuf dem im Formelschema skizzierten Wegen werden Azetidin‐Derivate wie (IV) und (X) dargestellt.
Piero Melloni, Arturo Della Torre, Anna Ambrosini, Alessandro Rossi, M. Meroni   +4 more
openaire   +4 more sources

Tricyclic Antidepressants in Obsessive-Compulsive Disorder Antiobsessional or Antidepressant Agents?

The Journal of Nervous and Mental Disease, 1983
The response to tricyclic antidepressants of eight obsessive-compulsive patients was assessed at pretreatment and at 4, 8, and 12 weeks of treatment, with the aim of delineating differential rates of improvement, or desynchrony, between the various symptoms. Change in obsessive-compulsive symptoms paralleled change in depression and anxiety, suggesting
Larry Michelson, Matig Mavissakalian
openaire   +2 more sources

Antidepressant agents: from tricyclics to serotonin uptake inhibitors

Psychological Medicine, 1998
Background. The number of antidepressant drugs available in the market has grown rapidly in the last few years. The present paper underlines some of the pre-clinical and clinical problems that call close attention from the regulatory authorities when approving new drugs.Methods. We present here a review of the literature.Results.
Garattini S., BARBUI, Corrado, Saraceno B.   +2 more
openaire   +4 more sources

CASE REPORT: Combined intoxication with a tricyclic antidepressive agent and a neuroleptic

European Journal of Emergency Medicine, 1996
We report the case of a patient who co-ingested a tricyclic antidepressant (2500 mg of doxepin) and a neuroleptic drug (3500 mg of prothipendyl). Following overdose either agent can affect the central nervous and cardiovascular systems, inducing arrhythmias, conduction disturbances and hypotension.
Ives Hubloue, Marc Diltoer, L. W. Poelmans, L. Huyghens, Herbert D. Spapen, V. Maes   +5 more
openaire   +3 more sources

Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II

American Journal of Psychiatry, 1985
The authors explored the relationship between the antiobsessional and antidepressant effects of tricyclic drugs in primary obsessive-compulsive disorders. Study 1 consisted of a controlled 12-week trial with clomipramine (N = 7) and placebo (N = 5); study 2 analyzed the pooled data from 15 patients uniformly selected and treated with either ...
Matig Mavissakalian, Samuel M. Turner, Larry Michelson, Rolf G. Jacob   +3 more
openaire   +2 more sources